Granted Patent B2

US 12,403,151 · App. 16/955,504 · Granted Sep 2, 2025

Inventors: Clara Lucia Garcia-Rodenas (Forel, CH); Jose Manuel Ramos Nieves (Lausanne, CH); Myriam Sandrine Steinmann (Echallens, CH)

Assignee: Societe des Produits Nestle S.A.

A61K31/702A23L33/135A23L33/40

Abstract

Claims (19)

1. A method of promoting intestinal motility in an infant or a young child, the method comprising administering a nutritional composition comprising an effective amount of an oligosaccharide mixture of 2′-fucosyllactose (2-FL) and lacto-N-neotetraose (LNnT), which is the only N-acetylated oligosaccharide to the infant or the young child.

2. The method according to claim 1 , wherein the method of promoting the intestinal motility is a method of promoting the motility in the small intestine.

3. The method according to claim 1 , wherein the method of promoting the intestinal motility is in a method of promoting intestinal contractile capacity in the infant or young child.

4. The method according to claim 1 , wherein the method of promoting the intestinal motility is a method of promoting development and/or growth of intestinal muscles in the infant or young child.

5. The method according to claim 4 , wherein the method of promoting the development and/or the growth of intestinal muscles is a method of promoting development and/or growth of the muscles of the small intestine.

6. The method according to claim 1 , wherein the method of promoting the intestinal motility is a method of increasing intestinal muscle thickness in the infant or young child.

7. A method of promoting enteral feeding tolerance in an infant or a young child, the method comprising:

administering a nutritional composition comprising an effective amount of an oligosaccharide mixture of 2′-fucosyllactose (2-FL) and lacto-N-neotetraose (LNnT), which is the only N-acetylated oligosaccharide in the composition, to the infant or the young child,

wherein the nutritional composition does not include any probiotics, wherein the infant or young child was born small for gestational age (SGA).

8. The method according to claim 1 , wherein the method of promoting the intestinal motility is a method of preventing and/or treating small intestinal bacterial overgrowth (SIBO).

9. The method according to claim 1 , wherein the composition comprises at least one additional oligosaccharide which is not an N-acetylated oligosaccharide.

10. The method according to claim 1 , wherein the LNnT is in a total amount of 0.005-3 g/L of the composition and/or in a total amount of 0.004-2.3 g/100 g of composition on a dry weight basis.

11. The method according to claim 1 , wherein the composition comprises at least another oligosaccharide(s) and/or fiber(s) and/or precursor(s) thereof selected from the group consisting of galacto-oligosaccharides (GOS), fructooligosaccharides (FOS), xylooligosaccharides (XOS), inulin, polydextrose, sialylated oligosaccharides, sialic acid, fucose and any combination thereof.

12. The method according to claim 1 , wherein the composition comprises at least one probiotic in an amount of from 10 3 to 10 12 cfu/g of the composition (dry weight).

13. The method according to claim 1 , wherein the nutritional composition is an infant formula, a starter infant formula, a follow-on or follow-up infant formula, a growing-up milk, a baby food, an infant cereal composition, a fortifier or a supplement.

14. The method of claim 7 , wherein the LNnT is in a total amount of 0.09-0.8 g/L of the nutritional composition and/or in a total amount of 0.07-0.6 g/100 g of the nutritional composition on a dry weight basis.

15. The method of claim 7 , wherein the infant or the young child was born preterm.

16. The method of claim 7 , wherein the oligosaccharide mixture of the nutritional composition consists of the 2′-fucosyllactose (2-FL) and the lacto-N-neotetraose (LNnT).

17. The method of claim 7 , wherein the nutritional composition is a fortifier or a supplement.

Assignments (2)

Priority Claims (1)

Continuity (1)

References Cited (18)